Trial
NCT02897115
A Study Treating Participants With Early Axial Spondyloarthritis (axSpA) Taking an Intense Treatment Approach Versus Routine Treatment
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
AbbVie
Collaborators
IST GmbH, Germany; Hannover Medical School; Improvement by Movement GmbH, Germany
Condition
Axial Spondyloarthritis
Intervention
Adalimumab
Why stopped
The study was terminated due to slow recruitment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-07-05